MEDEZE Participates in Thailand ATMP Roadmap 2025, Reinforcing Its Role in Advancing Thailand’s Advanced Medical Industry
Dr. Veerapol Khemarangsan, Chief Executive Officer, and Ms. Danita Phithaknetikun, Chief Business Development Officer, of Medeze Group Public Company Limited, or MEDEZE, participated in an exhibition booth showcasing the Company’s capabilities and business direction in Advanced Therapy Medicinal Products (ATMPs) at the Thailand ATMP Roadmap 2025: Fast-Track to Access & Innovation – Fastest in ASEAN conference. The event was held on 22–23 December 2025 at IMPACT Forum, Muang Thong Thani.
On this occasion, MEDEZE was honored by visits from Mr. Phadthana Phromphat, Minister of Public Health, and Dr. Somruek Jeungsaman, Permanent Secretary of the Ministry of Public Health, who toured the Company’s booth and received briefings on MEDEZE’s role in advancing advanced medical innovation—from stem cell banking (Biobank) to expanded applications in advanced therapies and the biomedical (Biopharma) industry.
MEDEZE’s participation underscores its commitment to supporting Thailand’s strategic ambition to become an ATMP hub in ASEAN, while contributing to the advancement of the national health ecosystem, medical research, and innovation. This aligns with the Company’s long-term vision to sustainably drive growth within the Health Economy in the future.
IR Press Releases